Preclinical models of multiple sclerosis in nonhuman primates

References

• Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol.47(6), 707–717 (2000).
   PubMed Web of Science ®Google Scholar
• Lassmann H. Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clin. Neurol. Neurosurg.104(3), 168–171 (2002).
   PubMedGoogle Scholar
• Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain129(Pt 8), 1953–1971 (2006).
   PubMed Web of Science ®Google Scholar
• ‘t Hart B, Amor S, Jonker M. Evaluating the validity of animal models for research into therapies for immune-based disorders. Drug Discov. Today9(12), 517–524 (2004).
   PubMed Web of Science ®Google Scholar
• Wiendl H, Hohlfeld R. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. BioDrugs16(3), 183–200 (2002).
   PubMed Web of Science ®Google Scholar
• Sachs DH. Tolerance: of mice and men. J. Clin. Invest.111(12), 1819–1821 (2003).
   PubMed Web of Science ®Google Scholar
• Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest.111(12), 1887–1895 (2003).
   PubMed Web of Science ®Google Scholar
• Lassmann H, Ransohoff RM. The CD4–Th1 model for multiple sclerosis: a crucial re-appraisal. Trends Immunol.25(3), 132–137 (2004).
   PubMed Web of Science ®Google Scholar
• Wilkin TJ. The primary lesion theory of autoimmunity: a speculative hypothesis. Autoimmunity7(4), 225–235 (1990).
   PubMed Web of Science ®Google Scholar
• Rorke LB, Iwasaki Y, Koprowski H et al. Acute demyelinating disease in a chimpanzee three years after inoculation of brain cells from a patient with MS. Ann. Neurol.5(1), 89–94 (1979).
   PubMedGoogle Scholar
• Wroblewska Z, Gilden D, Devlin M et al. Cytomegalovirus isolation from a chimpanzee with acute demyelinating disease after inoculation of multiple sclerosis brain cells. Infect. Immun.25(3), 1008–1015 (1979).
   PubMed Web of Science ®Google Scholar
• Scotet E, Peyrat MA, Saulquin X et al. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur. J. Immunol.29(3), 973–985 (1999).
   PubMed Web of Science ®Google Scholar
• Brok HP, Boven L, van Meurs M et al. The human CMV-UL86 peptide 981–1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34–56, but lacks the capacity to induce EAE in rhesus monkeys. J. Neuroimmunol.182(1–2), 135–152 (2007).
   PubMedGoogle Scholar
• Rivers TM, Sprunt DH, Berry GP. Observations on the attempts to produce acute disseminated allergic encephalomyelitis in primates. J. Exp. Med.58, 39–53 (1933).
   PubMedGoogle Scholar
• Rivers TM, Schwenkter FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med.61, 698–703 (1935).
   Google Scholar
• Kabat EA, Wolf A, Bezer AE. Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. IV disseminated encephalomyelitis produced in monkeys with their own brain tissue. J. Exp. Med.89, 395– 399 (1949).
   PubMedGoogle Scholar
• Geluk A, Elferink DG, Slierendregt BL et al. Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates. J. Exp. Med.177(4), 979–987 (1993).
   PubMed Web of Science ®Google Scholar
• ‘t Hart BA, Elferink DG, Drijfhout JW et al. Liposome-mediated peptide loading of MHC–DR molecules in vivo.FEBS Lett.409(1), 91–95 (1997).
   PubMedGoogle Scholar
• Rose LM, Richards TL, Petersen R, Peterson J, Hruby S, Alvord EC Jr. Remitting–relapsing EAE in nonhuman primates: a valid model of multiple sclerosis. Clin. Immunol. Immunopathol.59(1), 1–15 (1991).
   PubMedGoogle Scholar
• Rose LM, Richards T, Alvord EC Jr. Experimental allergic encephalomyelitis (EAE) in nonhuman primates: a model of multiple sclerosis. Lab. Anim. Sci.44(5), 508–512 (1994).
   PubMedGoogle Scholar
• ‘t Hart BA, Bauer J, Brok HP, Amor S. Non-human primate models of experimental autoimmune encephalomyelitis: variations on a theme. J. Neuroimmunol.168(1–2), 1–12 (2005).
   PubMedGoogle Scholar
• Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann. Neurol.37(4), 519–530 (1995).
   PubMed Web of Science ®Google Scholar
• ‘t Hart BA, Laman JD, Bauer J, Blezer ED, van Kooyk Y, Hintzen RQ. Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol.3, 589–597 (2004).
   Web of Science ®Google Scholar
• Mansfield K. Marmoset models commonly used in biomedical research. Comp. Med.53(4), 383–392 (2003).
   PubMed Web of Science ®Google Scholar
• Haig D. What is a marmoset? Am. J. Primatol.49(4), 285–296 (1999).
   PubMed Web of Science ®Google Scholar
• Genain CP, Nguyen MH, Letvin NL et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest.96(6), 2966–2974 (1995).
   PubMedGoogle Scholar
• Cadavid LF, Shufflebotham C, Ruiz FJ, Yeager M, Hughes AL, Watkins DI. Evolutionary instability of the major histocompatibility complex class I loci in New World primates. Proc. Natl Acad. Sci. USA94(26), 14536–14541 (1997).
   PubMedGoogle Scholar
• Rolleke U, Flugge G, Plehm S et al. Differential expression of major histocompatibility complex class I molecules in the brain of a New World monkey, the common marmoset (Callithrix jacchus). J. Neuroimmunol.176, 39–50 (2006).
   PubMedGoogle Scholar
• Antunes SG, de Groot NG, Brok H et al. The common marmoset: a new world primate species with limited MHC class II variability. Proc. Natl Acad. Sci. USA95(20), 11745–11750 (1998).
   PubMedGoogle Scholar
• Doxiadis GG, van der Wiel MK, Brok HP et al. Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species. Proc. Natl Acad. Sci. USA103(15), 5864–5868 (2006).
   PubMedGoogle Scholar
• Uccelli A, Oksenberg JR, Jeong MC et al. Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus.J. Immunol.158(3), 1201–1207 (1997).
   PubMedGoogle Scholar
• von Budingen HC, Hauser SL, Nabavi CB, Genain CP. Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus.Immunogenetics53(7), 557–563 (2001).
   PubMedGoogle Scholar
• Villinger F, Bostik P, Mayne A et al. Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules. Immunogenetics53(4), 315–328 (2001).
   PubMed Web of Science ®Google Scholar
• Brok HP, Hornby RJ, Griffiths GD, Scott LA, ‘t Hart BA. An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. Cytometry45(4), 294–303 (2001).
   PubMedGoogle Scholar
• ‘t Hart BA, Bauer J, Muller HJ et al. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am. J. Pathol.153(2), 649–663 (1998).
   PubMed Web of Science ®Google Scholar
• Brok HP, Bauer J, Jonker M et al. Non-human primate models of multiple sclerosis. Immunol. Rev.183, 173–185 (2001).
   PubMedGoogle Scholar
• Smith PA, Heijmans N, Ouwerling B et al. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur. J. Immunol.35(4), 1311–1319 (2005).
   PubMed Web of Science ®Google Scholar
• Delarasse C, Daubas P, Mars LT et al. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Invest.112(4), 544–553 (2003).
   PubMed Web of Science ®Google Scholar
• Brok HP, Uccelli A, Kerlero De Rosbo N et al. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24–36 is presented by a monomorphic MHC class II molecule. J. Immunol.165(2), 1093–1101 (2000).
   PubMed Web of Science ®Google Scholar
• Mancardi G, ‘t Hart B, Roccatagliata L et al. Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J. Neurol. Sci.184(1), 41–49 (2001).
   PubMedGoogle Scholar
• Ohler B, Graf K, Bragg R et al. Role of lipid interactions in autoimmune demyelination. Biochim. Biophys. Acta1688(1), 10–17 (2004).
   PubMedGoogle Scholar
• Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med.5(2), 170–175 (1999).
   PubMed Web of Science ®Google Scholar
• Harari A, Zimmerli SC, Pantaleo G. Cytomegalovirus (CMV)-specific cellular immune responses. Hum. Immunol.65(5), 500–506 (2004).
   PubMedGoogle Scholar
• Sylwester AW, Mitchell BL, Edgar JB et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med.202(5), 673–685 (2005).
   PubMed Web of Science ®Google Scholar
• Fabriek BO, Zwemmer JN, Teunissen CE et al.In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology. J. Neuroimmunol.161(1–2), 190–194 (2005).
   PubMedGoogle Scholar
• de Vos AF, van Meurs M, Brok HP et al. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol.169(10), 5415–5423 (2002).
   PubMed Web of Science ®Google Scholar
• Cserr HF, Harling-Berg CJ, Knopf PM. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol.2(4), 269–276 (1992).
   PubMed Web of Science ®Google Scholar
• Harling-Berg CJ, Park TJ, Knopf PM. Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J. Neuroimmunol.101(2), 111–127 (1999).
   PubMed Web of Science ®Google Scholar
• Weller RO, Engelhardt B, Phillips MJ. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol.6(3), 275–288 (1996).
   PubMed Web of Science ®Google Scholar
• Lake J, Weller RO, Phillips MJ, Needham M. Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE. J. Pathol.187(2), 259–265 (1999).
   PubMed Web of Science ®Google Scholar
• Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol.13(3), 227–231 (1983).
   PubMed Web of Science ®Google Scholar
• Barkhof F, Filippi M, Miller DH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain120(Pt 11), 2059–2069 (1997).
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology33(11), 1444–1452 (1983).
   PubMed Web of Science ®Google Scholar
• Villoslada P, Hauser SL, Bartke I et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med.191(10), 1799–1806 (2000).
   PubMed Web of Science ®Google Scholar
• ‘t Hart BA, Smith P, Amor S, Strijkers GJ, Blezer EL. MRI-guided immunotherapy development for multiple sclerosis in a primate. Drug Discov. Today11(1–2), 58–66 (2006).
   PubMedGoogle Scholar
• Blezer EL, Bauer J, Brok HP, Nicolay K, ‘t Hart BA. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed.20(2), 90–103 (2007).
   PubMedGoogle Scholar
• Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest.76(3), 355–364 (1997).
   PubMed Web of Science ®Google Scholar
• Laman JD, van Meurs M, Schellekens MM et al. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J. Neuroimmunol.86(1), 30–45 (1998).
   PubMedGoogle Scholar
• Genain CP, Abel K, Belmar N et al. Late complications of immune deviation therapy in a nonhuman primate. Science274(5295), 2054–2057 (1996).
   PubMed Web of Science ®Google Scholar
• Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods243(1–2), 147–154 (2000).
   PubMed Web of Science ®Google Scholar
• Sharma R, Anker SD. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int. J. Cardiol.85(1), 161–171 (2002).
   PubMed Web of Science ®Google Scholar
• Vierboom MP, Jonker M, Bontrop RE, ‘t Hart B. Modeling human arthritic diseases in nonhuman primates. Arthritis Res. Ther.7(4), 145–154 (2005).
   PubMed Web of Science ®Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med.338(5), 278–285 (1998).
   PubMed Web of Science ®Google Scholar
• ‘t Hart BA, Vogels JT, Bauer J, Brok HPM, Blezer E. Non-invasive measurement of brain damage in a primate model of multiple sclerosis. Trends Mol. Med.10(2), 85–91 (2004).
   PubMed Web of Science ®Google Scholar
• Philippens IH, Melchers BP, Roeling TA, Bruijnzeel PL. Behavioral test systems in marmoset monkeys. Behav. Res. Methods Instrum. Comput.32(1), 173–179 (2000).
   PubMedGoogle Scholar
• Scott L, Pearce P, Fairhall S, Muggleton N, Smith J. Training nonhuman primates to cooperate with scientific procedures in applied biomedical research. J. Appl. Anim. Welf. Sci.6(3), 199–207 (2003).
   PubMedGoogle Scholar
• Spinelli S, Pennanen L, Dettling AC, Feldon J, Higgins GA, Pryce CR. Performance of the marmoset monkey on computerized tasks of attention and working memory. Brain Res. Cogn. Brain Res.19(2), 123–137 (2004).
   PubMedGoogle Scholar